Literature DB >> 22652802

The role of melatonin treatment in chronic kidney disease.

Marije Russcher1, Birgit Koch, Elsbeth Nagtegaal, Karien van der Putten, Piet ter Wee, Carlo Gaillard.   

Abstract

The pineal hormone melatonin plays a major role in circadian sleep-wake rhythm. Patients with Chronic Kidney Disease (CKD), especially those who are on hemodialysis, frequently suffer from sleep disturbances. In this review an overview is given of the classification of stages of chronic kidney disease, followed by a presentation of the circadian rhythm disorders in renal disease involving sleep disturbances in relation to melatonin deficiency. The therapeutic benefit of melatonin treatment in sleep disorders related to chronic kidney disease including the controlled trials solving this topic, is described. Furthermore, the beneficial effect of melatonin on blood pressure alterations in CKD states and the protection of melatonin in oxidative stress and inflammation in renal disorders are explored. Finally a hypothetic model is described for the relation between circadian rhythm disorders and CKD.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22652802     DOI: 10.2741/4075

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  18 in total

1.  Analyses of melatonin, cytokines, and sleep in chronic renal failure.

Authors:  Aline Rodrigues Pinto; Nathani Cristina da Silva; Luciana Pinato
Journal:  Sleep Breath       Date:  2015-08-14       Impact factor: 2.816

Review 2.  Understanding the Two Faces of Low-Salt Intake.

Authors:  Branko Braam; Xiaohua Huang; William A Cupples; Shereen M Hamza
Journal:  Curr Hypertens Rep       Date:  2017-06       Impact factor: 5.369

Review 3.  Sleep disorders and chronic kidney disease.

Authors:  Stephanie C Maung; Ammar El Sara; Cherylle Chapman; Danielle Cohen; Daniel Cukor
Journal:  World J Nephrol       Date:  2016-05-06

4.  Impaired endogenous nighttime melatonin secretion relates to intrarenal renin-angiotensin system activation and renal damage in patients with chronic kidney disease.

Authors:  Sayaka Ishigaki; Naro Ohashi; Shinsuke Isobe; Naoko Tsuji; Takamasa Iwakura; Masafumi Ono; Yukitoshi Sakao; Takayuki Tsuji; Akihiko Kato; Hiroaki Miyajima; Hideo Yasuda
Journal:  Clin Exp Nephrol       Date:  2016-01-07       Impact factor: 2.801

5.  Melatonin ameliorates intrarenal renin-angiotensin system in a 5/6 nephrectomy rat model.

Authors:  Sayaka Ishigaki; Naro Ohashi; Takashi Matsuyama; Shinsuke Isobe; Naoko Tsuji; Takamasa Iwakura; Tomoyuki Fujikura; Takayuki Tsuji; Akihiko Kato; Hiroaki Miyajima; Hideo Yasuda
Journal:  Clin Exp Nephrol       Date:  2017-11-20       Impact factor: 2.801

Review 6.  Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension.

Authors:  Natalia Jorgelina Prado; León Ferder; Walter Manucha; Emiliano Raúl Diez
Journal:  Curr Hypertens Rep       Date:  2018-05-09       Impact factor: 5.369

Review 7.  Melatonin: shedding light on infertility?--A review of the recent literature.

Authors:  Shavi Fernando; Luk Rombauts
Journal:  J Ovarian Res       Date:  2014-10-21       Impact factor: 4.234

8.  Melatonin protects skin keratinocyte from hydrogen peroxide-mediated cell death via the SIRT1 pathway.

Authors:  Ju-Hee Lee; Ji-Hong Moon; Uddin Md Nazim; You-Jin Lee; Jae-Won Seol; Seong-Kug Eo; John-Hwa Lee; Sang-Youel Park
Journal:  Oncotarget       Date:  2016-03-15

9.  Melatonin prevents acute kidney injury in severely burned rats via the activation of SIRT1.

Authors:  Xiao-Zhi Bai; Ting He; Jian-Xin Gao; Yang Liu; Jia-Qi Liu; Shi-Chao Han; Yan Li; Ji-Hong Shi; Jun-Tao Han; Ke Tao; Song-Tao Xie; Hong-Tao Wang; Da-Hai Hu
Journal:  Sci Rep       Date:  2016-09-07       Impact factor: 4.379

Review 10.  Health risk of travel for chronic kidney disease patients.

Authors:  Yoshitaka Furuto; Mariko Kawamura; Akio Namikawa; Hiroko Takahashi; Yuko Shibuya
Journal:  J Res Med Sci       Date:  2020-03-18       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.